Bronchial epithelial cells: The key effector cells in the pathogenesis of chronic obstructive pulmonary disease?

Respirology - Tập 20 Số 5 - Trang 722-729 - 2015
Wei Gao1, Ling‐Ling Li1, Yujie Wang1, Sini Zhang1, Ian M. Adcock2, Peter J. Barnes2, Mao Huang1, Xin Yao1
1Department of Respiratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2Airway Disease Section, National Heart & Lung Institute, Imperial College, London, UK

Tóm tắt

Abstract

The primary function of the bronchial epithelium is to act as a defensive barrier aiding the maintenance of normal airway function. Bronchial epithelial cells (BEC) form the interface between the external environment and the internal milieu, making it a major target of inhaled insults. However, BEC can also serve as effectors to initiate and orchestrate immune and inflammatory responses by releasing chemokines and cytokines, which recruit and activate inflammatory cells. They also produce excess reactive oxygen species as a result of an oxidant/antioxidant imbalance that contributes to chronic pulmonary inflammation and lung tissue damage. Accumulated mucus from hyperplastic BEC obstructs the lumen of small airways, whereas impaired cell repair, squamous metaplasia and increased extracellular matrix deposition underlying the epithelium is associated with airway remodelling particularly fibrosis and thickening of the airway wall. These alterations in small airway structure lead to airflow limitation, which is critical in the clinical diagnosis of chronic obstructive pulmonary disease (COPD). In this review, we discuss the abnormal function of BEC within a disturbed immune homeostatic environment consisting of ongoing inflammation, oxidative stress and small airway obstruction. We provide an overview of recent insights into the function of the bronchial epithelium in the pathogenesis of COPD and how this may provide novel therapeutic approaches for a number of chronic lung diseases.

Từ khóa


Tài liệu tham khảo

10.1164/rccm.201204-0596PP

10.1146/annurev.pathol.4.110807.092145

10.1164/ajrccm.157.6.9707011

10.1152/ajplung.00155.2003

10.1046/j.1440-1843.2003.00493.x

10.1016/j.pharmthera.2008.11.001

10.1038/nri2236

10.1128/CMR.00014-10

10.1378/chest.08-0412

Müller L, 2012, Epithelial cells, the ‘switchboard’ of respiratory immune defense responses: effects of air pollutants, Swiss Med. Wkly, 142, w13653

10.1007/s00018-010-0500-x

10.1128/JVI.02074-10

10.1089/jir.2007.0054

10.1016/S0140-6736(11)60988-4

10.1164/rccm.200903-0340OC

10.1164/rccm.200910-1506OC

10.4049/jimmunol.178.5.3134

10.1056/NEJMra0804752

10.1183/09031936.03.00040703

10.1016/j.rmed.2010.06.018

10.4049/jimmunol.177.9.5912

10.1164/rccm.200608-1113OC

10.1046/j.1365-2222.1999.00644.x

10.1183/09031936.01.00228801

10.1016/S0140-6736(04)16900-6

10.1016/S0091-6749(03)02011-6

10.1111/j.1440-1843.2010.01920.x

10.2174/156801005774912806

10.1164/ajrccm.160.6.9902025

10.1124/mol.66.2.337

10.1164/rccm.200807-1158OC

10.1289/ehp.98106s51197

10.1016/j.tox.2009.01.028

10.1016/j.freeradbiomed.2014.01.026

10.1016/j.abb.2010.04.002

10.1164/rccm.201007-1113OC

10.1152/ajplung.00388.2005

10.1164/rccm.200607-931OC

10.1165/rcmb.2013-0304OC

10.1007/s12013-014-0330-9

10.1074/jbc.M113.536805

10.1165/rcmb.2008-0073OC

10.1016/j.intimp.2012.03.006

10.1165/rcmb.2010-0220RT

10.1165/ajrcmb.19.3.2961

10.1165/rcmb.2006-0214OC

10.1096/fj.00-0085com

10.1016/j.bbrc.2014.03.081

10.1165/ajrcmb.23.4.3959

10.1152/ajplung.00081.2007

10.1146/annurev.physiol.70.113006.100702

10.1378/chest.130.4.1102

10.1089/jamp.2009.0802

10.1165/rcmb.2009-0313OC

10.1124/mol.66.2.337

10.1152/ajplung.00440.2002

10.1016/j.pupt.2010.08.002

10.1016/j.intimp.2012.07.008

10.1165/rcmb.2006-0339OC

10.1164/rccm.200903-0328OC

10.1513/pats.2306018

10.1165/rcmb.2011-0273OC

10.1172/JCI39104

10.1007/s00408-009-9139-5

10.1111/j.1440-1843.2010.01808.x

10.1513/pats.200605-126SF

10.1590/S0100-879X2005001000009

10.1513/pats.200606-133SF

10.1517/17460441.2014.913020